ZTSZoetis Inc.

NYSE zoetis.com


$ 158.43 $ 5.06 (3.3 %)    

Friday, 26-Apr-2024 15:59:54 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 158.42
$ 152.92
$ 0.00 x 0
$ 0.00 x 0
$ 152.92 - $ 158.74
$ 144.80 - $ 200.89
5,236,463
na
73.23B
$ 0.98
$ 31.24
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-13-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-14-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-15-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 02-16-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-06-2020 03-31-2020 10-Q
17 02-13-2020 12-31-2019 10-K
18 11-07-2019 09-30-2019 10-Q
19 08-06-2019 08-06-2019 10-Q
20 05-02-2019 03-31-2019 10-Q
21 02-14-2019 12-31-2018 10-K
22 11-01-2018 09-30-2018 10-Q
23 08-02-2018 06-30-2018 10-Q
24 05-02-2018 03-31-2018 10-Q
25 02-15-2018 12-31-2017 10-K
26 11-02-2017 10-01-2017 10-Q
27 08-08-2017 07-02-2017 10-Q
28 05-04-2017 04-02-2017 10-Q
29 02-16-2017 12-31-2016 10-K
30 11-03-2016 10-02-2016 10-Q
31 08-05-2016 07-03-2016 10-Q
32 05-06-2016 04-03-2016 10-Q
33 02-24-2016 12-31-2015 10-K
34 11-05-2015 09-27-2015 10-Q
35 08-06-2015 06-28-2015 10-Q
36 05-07-2015 03-29-2015 10-Q
37 02-27-2015 12-31-2014 10-K
38 11-10-2014 09-28-2014 10-Q
39 08-12-2014 06-29-2014 10-Q
40 05-13-2014 03-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-overweight-on-zoetis-lowers-price-target-to-230

Barclays analyst Balaji Prasad maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $260 to $230.

 jack-daniels-parent-company-ea-cognizant-among-6-stocks-that-shine-when-nvidia-slips-analysis

The analysis screened S&P 500 stocks that show an inverse correlation to Nvidia over a month and year period, following Nvi...

 scout-clean-energy-announces-12-year-virtual-power-purchase-agreement-with-zoetis-inc

Scout Clean Energy (Scout), a Colorado-based renewable energy developer-owner-operator, is pleased to announce they have signed...

 piper-sandler-reiterates-overweight-on-zoetis-lowers-price-target-to-195

Piper Sandler analyst David Westenberg reiterates Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $220 ...

 why-jpmorgan-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

 animal-health-giant-zoetis-stock-crumbles-possible-side-effect-of-its-pet-arthritis-pain-drugs-sickened-dogs-cats

Zoetis' Solensia and Librela, pioneering arthritis treatments for pets. Despite recent concerns, Zoetis defends their safet...

 wall-street-journal-earlier-reported-what-killed-their-pets-owners-blame-meds-but-vets-arent-sure
maker-zoetis-says-side-effects-are-rare-and-its-arthritis-drugs-are-safe

https://www.wsj.com/health/pharma/dog-cat-arthritis-drugs-bcdddea6?page=1

 stifel-maintains-buy-on-zoetis-lowers-price-target-to-195

Stifel analyst Jonathan Block maintains Zoetis (NYSE:ZTS) with a Buy and lowers the price target from $215 to $195.

 largest-animal-health-firm-zoetis-hit-with-european-probe-over-possible-breach-of-competition-rules-related-to-dog-pain-medicine

The European Commission launches probe into Zoetis over alleged market interference in dog pain medication launch. Focus on Zoe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION